Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroguard for Prevention of Pelvic Adhesions
NCT03660787Phase 2Completed
- Sponsor
- Pharmasyntez
- Start
- May 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adezmapimod in Pelvic adhesions, sponsored by Pharmasyntez. Started May 2017; status: completed.
02
Drugs
adezmapimod
03
Conditions
Pelvic adhesions
Beyond the preview
Go deeper on NCT03660787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03660787.